Funded Tech Companies

Casma Therapeutics

Based in Cambridge, Casma Therapeutics has funding from Amgen Ventures, Astellas Venture Capital and Eisai.

Company Overview

Contact Information

Company Background Information

Overview

New discoveries are revealing the fundamental role of autophagy and lysosomal flux in maintaining cellular health. Furthermore, it is now appreciated that inadequate or aberrant autophagy contributes to a wide range of diseases. We are focused on boosting autophagy -- pioneering novel therapeutic strategies to address unmet medical needs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/15/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Keith Dionne

        

Chief Operating Officer

Frank Gentile

        

Chief Scientific Officer

Leon Murphy

        

Vice President

Daniel Ory

        

Vice President

Jeffrey Saunders

        

VP - Finance

Colleen DeSimone

        

VP - Human Resources

Caren Block

        

Company Investors

• Amgen Ventures
• Astellas Venture Capital
• Eisai
• Ono Venture Investment
• The Column Group (Millie Ray)
• Third Rock Ventures (Cary Pfeffer)
• Mirae Asset Capital
• Euclidean Capital
• Schroders Capital
• Eventide Asset Management (Finny Kuruvilla)
• Schroder Adveq

Browse more funded tech companies:

Cask Data | Casper Sleep

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary